9.39
price up icon2.07%   0.19
after-market アフターアワーズ: 9.02 -0.37 -3.94%
loading
前日終値:
$9.20
開ける:
$9.22
24時間の取引高:
3.01M
Relative Volume:
0.85
時価総額:
$1.04B
収益:
$631.73M
当期純損益:
$-239.78M
株価収益率:
-4.6485
EPS:
-2.02
ネットキャッシュフロー:
$-33.45M
1週間 パフォーマンス:
+7.07%
1か月 パフォーマンス:
+16.94%
6か月 パフォーマンス:
-29.61%
1年 パフォーマンス:
-63.31%
1日の値動き範囲:
Value
$8.95
$9.42
1週間の範囲:
Value
$8.70
$9.79
52週間の値動き範囲:
Value
$6.78
$25.65

10 X Genomics Inc Stock (TXG) Company Profile

Name
名前
10 X Genomics Inc
Name
セクター
Healthcare (1170)
Name
電話
(925) 401-7300
Name
住所
6230 STONERIDGE MALL ROAD, PLEASANTON, CA
Name
職員
1,306
Name
Twitter
@10xgenomics
Name
次回の収益日
2024-10-31
Name
最新のSEC提出書
Name
TXG's Discussions on Twitter

TXG を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Health Information Services icon
TXG
10 X Genomics Inc
9.39 1.08B 631.73M -239.78M -33.45M -2.02
Health Information Services icon
VEEV
Veeva Systems Inc
242.78 38.63B 2.75B 714.14M 1.09B 4.33
Health Information Services icon
TEM
Tempus Ai Inc
65.49 10.62B 803.32M -709.10M -212.68M -7.8003
Health Information Services icon
HQY
Healthequity Inc
98.23 7.82B 1.15B 96.70M -161.99M 1.09
Health Information Services icon
DOCS
Doximity Inc
52.56 11.11B 550.17M 201.35M 232.07M 1.00
Health Information Services icon
WAY
Waystar Holding Corp
39.34 6.92B 906.14M -52.62M 89.62M -0.3621

10 X Genomics Inc Stock (TXG) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-02-13 ダウングレード Leerink Partners Outperform → Market Perform
2024-09-03 開始されました Leerink Partners Outperform
2024-07-22 アップグレード Jefferies Hold → Buy
2024-07-18 ダウングレード JP Morgan Overweight → Neutral
2024-07-10 ダウングレード Deutsche Bank Buy → Hold
2024-06-27 ダウングレード Wolfe Research Outperform → Peer Perform
2024-06-25 ダウングレード Guggenheim Buy → Neutral
2024-06-03 再開されました Jefferies Hold
2024-05-01 ダウングレード TD Cowen Buy → Hold
2023-12-14 開始されました Guggenheim Buy
2023-12-13 開始されました Wolfe Research Outperform
2023-12-12 アップグレード BofA Securities Underperform → Neutral
2023-07-05 再開されました JP Morgan Overweight
2023-05-10 開始されました Barclays Overweight
2023-03-31 開始されました Stephens Overweight
2023-02-02 開始されました UBS Neutral
2022-12-14 開始されました Deutsche Bank Buy
2022-08-18 ダウングレード Goldman Neutral → Sell
2022-07-25 開始されました Canaccord Genuity Buy
2022-07-15 ダウングレード BofA Securities Neutral → Underperform
2022-07-15 ダウングレード William Blair Outperform → Mkt Perform
2021-10-15 再開されました Cowen Outperform
2021-09-14 ダウングレード BofA Securities Buy → Neutral
2021-03-15 開始されました William Blair Outperform
2020-12-02 開始されました Goldman Neutral
2020-09-09 開始されました Morgan Stanley Overweight
2020-07-10 開始されました Stifel Buy
2020-03-05 開始されました Guggenheim Buy
2020-01-07 開始されました Citigroup Buy
2019-10-07 開始されました BofA/Merrill Buy
2019-10-07 開始されました Cowen Outperform
2019-10-07 開始されました JP Morgan Overweight
2019-09-24 開始されました Evercore ISI Outperform
すべてを表示

10 X Genomics Inc (TXG) 最新ニュース

pulisher
06:56 AM

'Shooting ourselves in the foot': Trump administration cuts force East Bay’s 10x Genomics into layoffs - The Business Journals

06:56 AM
pulisher
May 15, 2025

NanoString to pay 10x Genomics $68m in global settlement - Life Sciences Intellectual Property Review

May 15, 2025
pulisher
May 15, 2025

10x Genomics reaches settlement with Bruker - Medical Buyer

May 15, 2025
pulisher
May 15, 2025

Stifel Financial Corp Raises Holdings in 10x Genomics, Inc. (NASDAQ:TXG) - Defense World

May 15, 2025
pulisher
May 15, 2025

UBS Group Lowers 10x Genomics (NASDAQ:TXG) Price Target to $12.00 - Defense World

May 15, 2025
pulisher
May 14, 2025

10x Genomics Reaches $68 Million Patent Settlement With Bruker - marketscreener.com

May 14, 2025
pulisher
May 14, 2025

10x Genomics Settles Litigation with Bruker Corporation - TipRanks

May 14, 2025
pulisher
May 14, 2025

10x Genomics settles patent dispute with Bruker for $68 million - Investing.com

May 14, 2025
pulisher
May 14, 2025

10x Genomics Wins Massive $68M Settlement Plus Royalties in Major Patent Battle with Bruker - Stock Titan

May 14, 2025
pulisher
May 14, 2025

All Ongoing Lawsuits Between Bruker And 10X Genomics To Be Withdrawn - marketscreener.com

May 14, 2025
pulisher
May 14, 2025

Earnings Release: Here's Why Analysts Cut Their 10x Genomics, Inc. (NASDAQ:TXG) Price Target To US$12.96 - simplywall.st

May 14, 2025
pulisher
May 14, 2025

10x Genomics (TXG) Price Target Reduced by UBS Amid Funding Chal - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Fierce Biotech Layoff Tracker 2025: Allogene cuts 28% of staff; Kyverna trims workforce by 16% - Fierce Biotech

May 14, 2025
pulisher
May 13, 2025

10x Genomics, Bruker Strike Deal After $31M Patent Verdict - Law360

May 13, 2025
pulisher
May 13, 2025

10x Genomics (TXG) Sees Price Target Lowered by UBS | TXG Stock News - GuruFocus

May 13, 2025
pulisher
May 13, 2025

UPC battle between 10x Genomics and Curio Bioscience moves to next stage - JUVE Patent

May 13, 2025
pulisher
May 13, 2025

UBS Adjusts Price Target on 10x Genomics to $12 From $14, Maintains Neutral Rating - marketscreener.com

May 13, 2025
pulisher
May 13, 2025

Canaccord Adjusts 10x Genomics (TXG) Price Target Citing Market Uncertainty | TXG Stock News - GuruFocus

May 13, 2025
pulisher
May 13, 2025

10x Genomics (NASDAQ:TXG) Price Target Lowered to $6.50 at The Goldman Sachs Group - Defense World

May 13, 2025
pulisher
May 13, 2025

10x Genomics (NASDAQ:TXG) Price Target Cut to $15.00 by Analysts at Canaccord Genuity Group - Defense World

May 13, 2025
pulisher
May 12, 2025

10x Genomics (TXG) Price Target Lowered by Canaccord Genuity | T - GuruFocus

May 12, 2025
pulisher
May 12, 2025

Analyst Expectations For 10x Genomics's Future - Benzinga

May 12, 2025
pulisher
May 12, 2025

JPMorgan Chase & Co. Cuts 10x Genomics (NASDAQ:TXG) Price Target to $9.00 - Defense World

May 12, 2025
pulisher
May 11, 2025

10x Genomics, Inc. (NASDAQ:TXG) Just Reported Earnings, And Analysts Cut Their Target Price - Yahoo Finance

May 11, 2025
pulisher
May 11, 2025

10x Genomics (NASDAQ:TXG) Shares Gap Up – Time to Buy? - Defense World

May 11, 2025
pulisher
May 11, 2025

10x Genomics (NASDAQ:TXG) Receives Sell (E+) Rating from Weiss Ratings - Defense World

May 11, 2025
pulisher
May 10, 2025

10x Genomics First Quarter 2025 Earnings: Beats Expectations - simplywall.st

May 10, 2025
pulisher
May 10, 2025

30,005 Shares in 10x Genomics, Inc. (NASDAQ:TXG) Purchased by Raymond James Financial Inc. - Defense World

May 10, 2025
pulisher
May 10, 2025

10x Genomics, Inc. (NASDAQ:TXG) Q1 2025 Earnings Call Transcript - Insider Monkey

May 10, 2025
pulisher
May 09, 2025

JPMorgan Adjusts Price Target for 10x Genomics (TXG) Amid Market Concerns | TXG Stock News - GuruFocus

May 09, 2025
pulisher
May 09, 2025

10x Genomics (TXG) Price Target Lowered to $9 by JP Morgan | TXG Stock News - GuruFocus

May 09, 2025
pulisher
May 09, 2025

10x Genomics (TXG) Faces Price Target Reduction Amid Uncertain O - GuruFocus

May 09, 2025
pulisher
May 09, 2025

Stifel Adjusts 10x Genomics (TXG) Price Target Amid Funding Conc - GuruFocus

May 09, 2025
pulisher
May 09, 2025

Deutsche Bank Adjusts Price Target on 10x Genomics to $10 From $16, Maintains Hold Rating - marketscreener.com

May 09, 2025
pulisher
May 09, 2025

Stifel Adjusts 10x Genomics (TXG) Price Target Amid Funding Concerns | TXG Stock News - GuruFocus

May 09, 2025
pulisher
May 09, 2025

10x Genomics (TXG) Faces Price Target Reduction Amid Uncertain Outlook | TXG Stock News - GuruFocus

May 09, 2025
pulisher
May 09, 2025

10x Genomics Inc (TXG) Q1 2025 Earnings Call Highlights: Navigat - GuruFocus

May 09, 2025
pulisher
May 09, 2025

10x Genomics (NASDAQ:TXG) adds US$65m to market cap in the past 7 days, though investors from five years ago are still down 89% - simplywall.st

May 09, 2025
pulisher
May 09, 2025

10x Genomics, Inc. SEC 10-Q Report - TradingView

May 09, 2025
pulisher
May 09, 2025

10x Genomics Reports First Quarter 2025 Financial Results - BioSpace

May 09, 2025
pulisher
May 09, 2025

10x Genomics Inc (TXG) Q1 2025 Earnings Call Highlights: Navigating Challenges with Strategic ... - Yahoo Finance

May 09, 2025
pulisher
May 09, 2025

10x Genomics Inc (TXG) Q1 2025 Earnings Call Highlights: Navigating Challenges with Strategic Initiatives - GuruFocus

May 09, 2025
pulisher
May 09, 2025

10x Genomics CEO Calls NIH The 'Foundational Jewel' Of Biomedical Progress, Says 40% To 50% Of Revenue Supported By Academic And Government Research Funding — Pulls Full Year Revenue Guidance - Benzinga

May 09, 2025
pulisher
May 08, 2025

10x Genomics: Q1 Earnings Snapshot - CTPost

May 08, 2025
pulisher
May 08, 2025

Compared to Estimates, 10x Genomics (TXG) Q1 Earnings: A Look at Key Metrics - Yahoo Finance

May 08, 2025
pulisher
May 08, 2025

10x Genomics’s (NASDAQ:TXG) Q1: Strong Sales But Quarterly Revenue Guidance Significantly Misses Expectations - Yahoo Finance

May 08, 2025
pulisher
May 08, 2025

10x Genomics (TXG) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance

May 08, 2025
pulisher
May 08, 2025

10x Genomics Announces Workforce Reduction to Cut Costs - TipRanks

May 08, 2025
pulisher
May 08, 2025

10x Genomics Inc Q1 2025 Earnings: EPS of -$0.28 Beats Estimate, Revenue Surges to $154.9 Million - GuruFocus

May 08, 2025
pulisher
May 08, 2025

Earnings Flash (TXG) 10x Genomics Posts Q1 Loss $-0.28 Per Share, vs. FactSet Est of $-0.47 - marketscreener.com

May 08, 2025
pulisher
May 08, 2025

10x Genomics (NASDAQ:TXG) shareholders have endured a 90% loss from investing in the stock five years ago - Yahoo Finance

May 08, 2025

10 X Genomics Inc (TXG) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

10 X Genomics Inc (TXG) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Saxonov Serge
Chief Executive Officer
Feb 28 '25
Sale
10.63
7,942
84,393
871,540
$23.58
price up icon 0.94%
$23.12
price up icon 1.45%
$11.88
price up icon 2.24%
$25.02
price up icon 0.48%
$24.43
price up icon 1.71%
health_information_services WAY
$39.34
price up icon 0.23%
大文字化:     |  ボリューム (24 時間):